← Leaderboards
Barry J. Hoffer
University Of Colorado Denver
$147,576
Attributed
$147,576
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$147,576 · 1
By mechanism
P01$147,576 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Andre Francis Palmer$9,637,181
- Paco S Herson$11,691,083
- Gregory G Schwartz$4,146,602
- Maria Acena Nagel$8,256,702
- Tobias De La Garza Eckle$2,976,418
Others in their field
Top investigators on “Laboratory Rat”
- Barney Sparrow · Battelle Memorial Institute$68,853,027
- Richard A Gibbs · Baylor College Of Medicine$59,652,654
- Howard J Jacob · Medical College Of Wisconsin$35,611,302
- David Heimbrook · Leidos Biomedical Research, Inc.$26,424,278
- Milton D Hejtmancik · Battelle Centers/Pub Hlth Res & Evaluatn$24,972,057
- Charles Hebert · Southern Research Institute$24,146,988
Research focus
Laboratory RatLaboratory MouseNeurotrophic FactorsStrokeNeuroprotectantsParkinson'S DiseaseNonhuman Therapy EvaluationCerebral Ischemia /HypoxiaGene ExpressionHippocampusSubstantia NigraCorpus StriatumImmunocytochemistryGenetically Modified AnimalsNeurotoxicologyPhenotypeDopamineReceptor ExpressionStroke TherapyGene TherapyLocus CoeruleusNeuropharmacologyAgingTranscription Factor
Grant awards (32)
Studies on CDNF: a new class of neurotrophic proteins$494,841
Z01 · FY2007 · DA · contact PI
Inducible Cre expression through the Rosa 26 locus of recombinant mice$494,841
Z01 · FY2007 · DA · contact PI
The mt-DNA mutator mouse$494,841
Z01 · FY2007 · DA · contact PI
The MitoPark mouse--a new model for Parkinson's Disease$494,841
Z01 · FY2007 · DA · contact PI
The Noradrenergic System Of Aged Gdnf Heterozygous Mice$0
Z01 · FY2004 · DA
The Noradrenergic System Of Aged Gdnf Heterozygous Mice$0
Z01 · FY2003 · DA
siRNAs for Reducing Phenotypic Markers and Studying Gene$0
Z01 · FY2003 · DA
BAC Transgenic Mice Encoding Tau Green Through the Nurr*$0
Z01 · FY2003 · DA
The Noradrenergic System Of Aged Gdnf Heterozygous Mice$0
Z01 · FY2002 · DA
Park2, A Parkinson Candidate Gene, Mapped To The Telomer$0
Z01 · FY2002 · DA
Aav-gdnf Promotes Recovery Of Dopaminergic Phenotype Aft$0
Z01 · FY2002 · DA
Bradykinin receptor agonist facilitates low-dose Cyclosp$0
Z01 · FY2002 · DA
Effects Of Cerebral Ischemia In Mice Deficient In Persep$0
Z01 · FY2002 · DA
Gene Therapy In An Animal Model Of Parkinson$0
Z01 · FY2001 · DA
Characterization Of Gdnf Alpha 1 (gfr Alpha 1) Receptor$0
Z01 · FY2001 · DA
Methamphetamine Exposure And The Nurr1/nurr77 System$0
Z01 · FY2001 · DA
Phenotypic Characterization Of The Nurr77 System$0
Z01 · FY2001 · DA
Intraventricular administration of BMP7 in stroke animal$0
Z01 · FY2001 · DA
Transplantation Therapy For Chronic Stroke$0
Z01 · FY2001 · DA
Blood Brain Barrier Opening With Bradykinin Agonists$0
Z01 · FY2001 · DA
Cannabinoids And Opioids On Synaptic Transmission$0
Z01 · FY2001 · DA
Fetal Kidney Tissue Transplantation And Bmp7$0
Z01 · FY2001 · DA
Gene Therapy And Neuroprotection$0
Z01 · FY2001 · DA
PHARMACOLOGICAL CORRELATES OF AGING IN BRAIN CELL GRAFTS$147,576
P01 · FY2000 · AG
Gene therapy in an animal model of parkinson's disease$0
Z01 · FY2000 · DA
Cannabinoids &opioids on synaptic transmission in nucle$0
Z01 · FY2000 · DA
Blood brain barrier opening with bradykinin agonists$0
Z01 · FY2000 · DA
TRANSPLANTATION THERAPY FOR CHRONIC STROKE$0
Z01 · FY2000 · DA
THERAPEUTIC STRATEGIES FOR STROKE$0
Z01 · FY2000 · DA
PHENOTYPIC CHARACTERIZATION OF THE NURR77 SYSTEM$0
Z01 · FY2000 · DA
METHAMPHETAMINE EXPOSURE AND THE NURR1/NURR77 SYSTEM$0
Z01 · FY2000 · DA
CHARACTERIZATION OF GDNF ALPHA 1 (GFR ALPHA 1) RECEPTOR IN STROKE$0
Z01 · FY2000 · DA